BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ATTO-1310 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ATTO-1310\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07833306-1299@assetmemo.bio
DTSTAMP:20261121T005646Z
DTSTART;VALUE=DATE:20280830
DTEND;VALUE=DATE:20280831
SUMMARY:ATTO-1310: Phase 2 readout est. (NCT07833306)
DESCRIPTION:ATTO-1310\, phase 2.\nStudy: Efficacy and Safety of ATTO-1310 i
 n the Treatment of Participants With Chronic Pruritus of Unknown Origin\nE
 stimated primary completion: 30 August 2028. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/atto-1310#upcoming-events\nRegistry record: https:
 //clinicaltrials.gov/study/NCT07833306
URL:https://assetmemo.bio/drug/atto-1310#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
